Orally bioavailable tubulin antagonists for paclitaxel-refractory cancer.
Li CM, Lu Y, Chen J, Costello TA, Narayanan R, Dalton MN, Snyder LM, Ahn S, Li W, Miller DD, Dalton JT.
Li CM, et al. Among authors: lu y.
Pharm Res. 2012 Nov;29(11):3053-63. doi: 10.1007/s11095-012-0814-5. Epub 2012 Jul 4.
Pharm Res. 2012.
PMID: 22760659
Free PMC article.